Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Pandor, A., Pollard, D., Chico, T. et al. (2 more authors) (2015) Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
  • Pandor, A.
  • Pollard, D.
  • Chico, T.
  • Henderson, R.
  • Stevenson, M.
Copyright, Publisher and Additional Information: © Crown Copyright 2015. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 21 December 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 22 Jan 2016 09:33
Last Modified: 21 Dec 2016 11:05
Published Version: http://dx.doi.org/10.1007/s40273-015-0351-2
Status: Published
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-015-0351-2
Related URLs:

Export

Statistics